About iaslc

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 3,500 lung cancer specialists in 80 countries.

 

IASLC members work to enhance the understanding of lung cancer among scientists, members of the medical community and the public. IASLC publishes the Journal of Thoracic Oncology, a valuable resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer.

 

Our mission:

• to embrace the study of the etiology, epidemiology, prevention, diagnosis, treatment and all other aspects of lung cancer and other thoracic malignancies

• to provide education and information about lung cancer and other thoracic malignancies to IASLC members, to the medical community at large, and to the public

• to use all available means to eliminate lung cancer and other thoracic malignancies as a health threat for the individual patient and throughout the world 

 

The IASLC's Journal is the Journal of Thoracic Oncology.

 

Become a member of IASLC and receive a complimentary subscription to the Journal of Thoracic Oncology.  JTO emphasizes a multidisciplinary approach and includes original research (clinical trials and translational or basis research), reviews, and opinion pieces.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MEET THE EDITOR     Alex A. Adjei, M.D., PhD, FACP Dr. Adjei is Editor in Chief of the Journal of Thoracic Oncology (JTO). Dr. Adjei is Professor and Chair of the Department of Medicine and the Katherine Anne Gioia Chair in Cancer Medicine at Roswell Park Cancer Institute in Buffalo, New York.